AbolerIS Pharma Takes a Major Step in Rheumatoid Arthritis Treatment with First Patient Dosed in Phase 1 Study AbolerIS Pharma marks a significant milestone in autoimmune treatment with the first patient dosed in a Phase 1 study of ABO21009 for rheumatoid arthritis.

AbolerIS Pharma Takes a Major Step in Rheumatoid Arthritis Treatment with First Patient Dosed in Phase 1 Study #Belgium #rheumatoid_arthritis #ABO21009 #Gosselies #AbolerIS

AbolerIS Pharma Reveals Breakthrough Research on New Antibody for Autoimmune Treatments AbolerIS Pharma recently published new preclinical findings on ABO21009, a pioneering anti-CD45RC antibody that shows promise in treating autoimmune diseases.

AbolerIS Pharma Reveals Breakthrough Research on New Antibody for Autoimmune Treatments #Belgium #Autoimmune_Diseases #AbolerIS_Pharma #ABO21009 #Gosselies

AbolerIS Pharma’s Breakthrough in Rheumatoid Arthritis Treatment with ABO21009 AbolerIS Pharma has initiated a Phase 1 study for ABO21009, a novel anti-CD45RC antibody aimed at treating rheumatoid arthritis, addressing unmet medical needs.

AbolerIS Pharma’s Breakthrough in Rheumatoid Arthritis Treatment with ABO21009 #Belgium #rheumatoid_arthritis #AbolerIS_Pharma #ABO21009 #Gosselies

AbolerIS Pharma Launches Phase 1 Study for Novel Rheumatoid Arthritis Treatment AbolerIS Pharma has initiated a Phase 1 trial of ABO21009, a new anti-CD45RC antibody aimed at treating rheumatoid arthritis, with promising implications for future therapies.

AbolerIS Pharma Launches Phase 1 Study for Novel Rheumatoid Arthritis Treatment #Belgium #rheumatoid_arthritis #ABO21009 #Gosselies #AbolerIS

AbolerIS Pharma Establishes Scientific Advisory Board for Advancing Treatment of Autoimmune Diseases AbolerIS Pharma has announced the formation of its Scientific Advisory Board to push forward its lead program ABO21009 for rheumatoid arthritis and beyond.

AbolerIS Pharma Establishes Scientific Advisory Board for Advancing Treatment of Autoimmune Diseases #Belgium #Autoimmune_Disease #AbolerIS_Pharma #ABO21009 #Gosselies